ReviewFrontiers in immunology2020

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.

Marion Anliker-Ort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.